{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:46:43Z","timestamp":1775656003079,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.clp.2013.05.015","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T16:00:58Z","timestamp":1372953658000},"page":"337-350","source":"Crossref","is-referenced-by-count":26,"title":["Chronic Opioid Use During Pregnancy"],"prefix":"10.1016","volume":"40","author":[{"given":"Todd J.","family":"Stanhope","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clp.2013.05.015_bib1","article-title":"America\u2019s most popular drugs","author":"Herper","year":"2010","journal-title":"Forbes"},{"issue":"Suppl 3","key":"10.1016\/j.clp.2013.05.015_bib2","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.clp.2013.05.015_bib3","unstructured":"Available at: http:\/\/www.justice.gov\/dea\/druginfo\/ds.shtml. Accessed January 9, 2013."},{"key":"10.1016\/j.clp.2013.05.015_bib4","unstructured":"Code of Federal Regulations title 21. Available at: http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfCFR\/CFRSearch.cfm?fr=201.57. Accessed January 9, 2013."},{"key":"10.1016\/j.clp.2013.05.015_bib5","series-title":"Goodman and Gilman\u2019s the Pharmacological basis of Therapeutics","first-page":"481","article-title":"Opioid analgesics and pain management","author":"Yaksh","year":"2010"},{"key":"10.1016\/j.clp.2013.05.015_bib6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ejpain.2011.08.008","article-title":"Peripartum pain management in opioid dependent women","volume":"16","author":"Hoflich","year":"2012","journal-title":"Eur J Pain"},{"issue":"2","key":"10.1016\/j.clp.2013.05.015_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1509\/jppm.25.2.133","article-title":"The marketing of opioid prescriptions without prescription over the internet","volume":"25","author":"Forman","year":"2006","journal-title":"J Publ Pol Market"},{"issue":"20","key":"10.1016\/j.clp.2013.05.015_bib8","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1001\/jama.2011.1712","article-title":"Can prescription drug monitoring programs help limit opioid abuse?","volume":"306","author":"Gugelmann","year":"2011","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.clp.2013.05.015_bib9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1526-4637.2011.01062.x","article-title":"Prescription drug monitoring programs and death rates from drug overdose","volume":"12","author":"Paulozzi","year":"2011","journal-title":"Pain Med"},{"issue":"6","key":"10.1016\/j.clp.2013.05.015_bib10","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1526-4637.2011.01136.x","article-title":"Revisiting Paulozzi et\u00a0al.'s \u201cPrescription drug monitoring programs and death rates from drug overdose\u201d","volume":"12","author":"Green","year":"2011","journal-title":"Pain Med"},{"issue":"5","key":"10.1016\/j.clp.2013.05.015_bib11","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e318256496e","article-title":"Opioid abuse, dependence, and addiction in pregnancy. Committee Opinion No. 524","volume":"119","author":"American College of Obstetricians and Gynecologists","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2013.05.015_bib12","series-title":"Treatment improvement protocol series 2: pregnant, substance-using women","first-page":"14","article-title":"Alcohol and other drug treatment guidelines for pregnant, substance using women","author":"Mitchell","year":"1995"},{"issue":"4","key":"10.1016\/j.clp.2013.05.015_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0899-3289(20)30008-0","article-title":"Altered methadone pharmacokinetics in pregnancy: implications for dosing","volume":"1","author":"Swift","year":"1989","journal-title":"J\u00a0Subst Abuse"},{"issue":"2","key":"10.1016\/j.clp.2013.05.015_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/10826089509060743","article-title":"Methadone dosing and pregnancy: impact on program compliance","volume":"30","author":"DePetrillo","year":"1995","journal-title":"Int J Addict"},{"issue":"1","key":"10.1016\/j.clp.2013.05.015_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14767050802452291","article-title":"Maternal methadone dosing schedule and fetal neurobehaviour","volume":"22","author":"Jansson","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"5","key":"10.1016\/j.clp.2013.05.015_bib16","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1067\/mob.2002.127132","article-title":"Methadone trough levels in pregnancy","volume":"187","author":"Drozdick","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.clp.2013.05.015_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.0001-6349.2005.00497.x","article-title":"Methadone maintenance program in a Swiss perinatal center: (I): management and outcome of 89 pregnancies","volume":"84","author":"Kashiwagi","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.clp.2013.05.015_bib18","doi-asserted-by":"crossref","first-page":"F258","DOI":"10.1136\/adc.2009.163105","article-title":"Growth restriction in pregnancies of opioid-dependent mothers","volume":"95","author":"Liu","year":"2010","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"10.1016\/j.clp.2013.05.015_bib19","first-page":"1","article-title":"Management of addiction disorders in pregnancy","volume":"2","author":"Helmbrecht","year":"2008","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.clp.2013.05.015_bib20","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"The transfer of drugs and other chemicals into human breast milk","volume":"108","author":"Committee on Drugs, American Academy of Pediatrics","year":"2001","journal-title":"Pediatrics"},{"issue":"24","key":"10.1016\/j.clp.2013.05.015_bib21","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.clp.2013.05.015_bib22","first-page":"CD006318","article-title":"Maintenance agonist treatments for opiate dependent pregnant women","author":"Minozzi","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.clp.2013.05.015_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ajog.2011.04.001","article-title":"Management of women treated with buprenorphine during pregnancy","volume":"205","author":"Alto","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.clp.2013.05.015_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent women: a comprehensive review","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.clp.2013.05.015_bib25","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0029-7844(98)00312-3","article-title":"Opioid detoxification in pregnancy","volume":"92","author":"Dashe","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"9148","key":"10.1016\/j.clp.2013.05.015_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","article-title":"Role of maintenance treatment in opioid dependence","volume":"353","author":"Ward","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2013.05.015_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10550490490460256","article-title":"Buprenorphine: a safe method for detoxifying pregnant heroin addicts and their unborn","volume":"13","author":"Comer","year":"2004","journal-title":"Am J Addict"},{"key":"10.1016\/j.clp.2013.05.015_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/10550490050172272","article-title":"Detoxification with buprenorphine of a pregnant heroin addict","volume":"9","author":"Annitto","year":"2000","journal-title":"Am J Addict"},{"key":"10.1016\/j.clp.2013.05.015_bib29","series-title":"Results from the 2011 National Survey on drug use and health: summary of National Findings","author":"Substance Abuse and Mental Health Services Administration","year":"2012"},{"key":"10.1016\/j.clp.2013.05.015_bib30","series-title":"Tintinalli\u2019s emergency medicine","article-title":"Chapter 180. Opioids","author":"Doyon","year":"2011"},{"issue":"5","key":"10.1016\/j.clp.2013.05.015_bib31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/10550490802266276","article-title":"Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes","volume":"17","author":"Jones","year":"2008","journal-title":"Am J Addict"},{"issue":"3","key":"10.1016\/j.clp.2013.05.015_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/YCO.0b013e3282fb25e5","article-title":"Opioid dependence and pregnancy","volume":"21","author":"Winklbaur","year":"2008","journal-title":"Curr Opin Psychiatry"},{"issue":"11","key":"10.1016\/j.clp.2013.05.015_bib33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.ogx.0000286562.31774.76","article-title":"Illicit drug use and neonatal outcomes: a critical review","volume":"62","author":"Schempf","year":"2007","journal-title":"Obstet Gynecol Surv"},{"issue":"4","key":"10.1016\/j.clp.2013.05.015_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.12.039","article-title":"National birth defects prevention study. Maternal treatment with opioid analgesics and risk for birth defects","volume":"204","author":"Broussard","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"7656","key":"10.1016\/j.clp.2013.05.015_bib35","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/bmj.39514.554375.AE","article-title":"Pregnancy and injecting drug use","volume":"336","author":"Bell","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.clp.2013.05.015_bib36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.psym.2012.04.003","article-title":"Evaluation and management of opioid dependence in pregnancy","volume":"53","author":"Park","year":"2012","journal-title":"Psychosomatics"},{"issue":"3 Pt 1","key":"10.1016\/j.clp.2013.05.015_bib37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ajog.2005.02.075","article-title":"Fetal response to maternal methadone administration","volume":"193","author":"Jansson","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.clp.2013.05.015_bib38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2165\/11632820-000000000-00000","article-title":"Methadone and buprenorphine for the management of opioid dependence in pregnancy","volume":"72","author":"Jones","year":"2012","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.clp.2013.05.015_bib39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jsgi.2005.11.001","article-title":"Effect of chronic maternal methadone therapy on intrapartum fetal heart rate patterns","volume":"13","author":"Ramirez-Cacho","year":"2006","journal-title":"J\u00a0Soc Gynecol Investig"},{"issue":"3","key":"10.1016\/j.clp.2013.05.015_bib40","doi-asserted-by":"crossref","first-page":"259.e1","DOI":"10.1016\/j.ajog.2010.12.050","article-title":"Current trends in narcotic use in pregnancy and neonatal outcomes","volume":"204","author":"Kellogg","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.clp.2013.05.015_bib41","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.pcl.2009.03.003","article-title":"Delivery room management of the Newborn","volume":"56","author":"Rajani","year":"2009","journal-title":"Pediatr Clin North Am"},{"issue":"2","key":"10.1016\/j.clp.2013.05.015_bib42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MOP.0b013e32834fdc3a","article-title":"Neonatal abstinence syndrome","volume":"24","author":"Jansson","year":"2012","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"10.1016\/j.clp.2013.05.015_bib43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jsat.2010.11.007","article-title":"Higher maternal doses of methadone does not increase neonatal abstinence syndrome","volume":"40","author":"Pizarro","year":"2011","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"6","key":"10.1016\/j.clp.2013.05.015_bib44","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0029-7844(02)02387-6","article-title":"Relationship between maternal methadone dosage and neonatal withdrawal","volume":"100","author":"Dashe","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2013.05.015_bib45","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"issue":"18","key":"10.1016\/j.clp.2013.05.015_bib46","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.clp.2013.05.015_bib47","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00228-011-1030-7","article-title":"Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study","volume":"67","author":"Handal","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.clp.2013.05.015_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.earlhumdev.2007.01.013","article-title":"Adverse neurodevelopmental outcome of infants exposed to opiate in-utero","volume":"84","author":"Hunt","year":"2008","journal-title":"Early Hum Dev"},{"issue":"1","key":"10.1016\/j.clp.2013.05.015_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2012.04.008","article-title":"Neural tract development of infants born to methadone-maintained mothers","volume":"47","author":"Walhovd","year":"2012","journal-title":"Pediatr Neurol"},{"issue":"6","key":"10.1016\/j.clp.2013.05.015_bib50","doi-asserted-by":"crossref","first-page":"F457","DOI":"10.1136\/adc.2009.181057","article-title":"The management of heroin misuse in pregnancy: time for a rethink?","volume":"96","author":"Mactier","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.clp.2013.05.015_bib51","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.resuscitation.2010.08.027","article-title":"2010 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations","volume":"81S","author":"Deakin","year":"2010","journal-title":"Resuscitation"},{"key":"10.1016\/j.clp.2013.05.015_bib52","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1161\/CIRCULATIONAHA.110.971069","volume":"122","author":"Vanden Hoek","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.clp.2013.05.015_bib53","series-title":"Harrison\u2019s principles of internal medicine","article-title":"Chapter 393. Opioid drug abuse and dependence","author":"Kosten","year":"2012"},{"issue":"4","key":"10.1016\/j.clp.2013.05.015_bib54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jsat.2010.01.006","article-title":"Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment","volume":"38","author":"M\u00e9garbane","year":"2010","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.clp.2013.05.015_bib55","first-page":"10","article-title":"CDC grand rounds: prescription drug overdoses\u2014a U.S. epidemic","volume":"61","author":"Paulozzi","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"17","key":"10.1016\/j.clp.2013.05.015_bib56","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1056\/NEJMp1208498","article-title":"Why doctors prescribe opioids to known opioid abusers","volume":"367","author":"Lembke","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.clp.2013.05.015_bib57","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMp1011512","article-title":"A\u00a0flood of opioids, a rising tide of deaths","volume":"363","author":"Okie","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2013.05.015_bib58","unstructured":"US Food and Drug Administration Risk Evaluation and Mitigation Strategy (REMS) for Extended-Release and Long-Acting Opioids. Retrieved from the FDA website: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/InformationbyDrugClass\/ucm309742.htm. Accessed December 17, 2012."},{"issue":"5","key":"10.1016\/j.clp.2013.05.015_bib59","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/jama.2012.8165","article-title":"Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS)","volume":"308","author":"Nelson","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2013.05.015_bib60","unstructured":"DEA Drug Scheduling. Retrieved from the United States Drug Enforcement Agency website: http:\/\/www.justice.gov\/dea\/druginfo\/ds.shtml. Accessed December 17, 2012."},{"issue":"4","key":"10.1016\/j.clp.2013.05.015_bib61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3928\/02793695-20090401-06","article-title":"Categorizing the safety of medications during pregnancy and lactation","volume":"47","author":"Howland","year":"2009","journal-title":"J\u00a0Psychosoc Nurs Ment Health Serv"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510813000705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510813000705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T22:30:17Z","timestamp":1715639417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510813000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0095510813000705"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2013.05.015","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}